Alexander Mustea
Impact in
- Reproductive Medicine top 0.5%
- Ovarian cancer diagnosis and treatment
- Endometriosis Research and Treatment
- Obstetrics and Gynecology top 1%
- Endometrial and Cervical Cancer Treatments
Papers in
-
- Ovarian cancer diagnosis and treatment 48
- Endometriosis Research and Treatment 9
-
- Endometrial and Cervical Cancer Treatments 15
- Uterine Myomas and Treatments 13
- Co-authors
- Jalid SehouliDominique KoensgenW. LichteneggerDominique KönsgenPeter AltevogtSascha KellerSteffen RunzMatthias B. Stope
- Journals
- Anticancer Research (12 papers)Journal of Clinical Oncology (11 papers)Archives of Gynecology and Obstetrics (7 papers)Annals of Oncology (5 papers)Gynecologic Oncology (5 papers)
- Partner nations
- GermanyAustriaUnited States
In The Last Decade
Alexander Mustea
139 papers receiving 3.1k citations
Peers
Comparison fields: 5 of 130
- Reproductive Medicine 838
- Obstetrics and Gynecology 440
- Cancer Research 837
- Oncology 720
- Immunology 478
Countries citing papers authored by Alexander Mustea
This map shows the geographic impact of Alexander Mustea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander Mustea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander Mustea more than expected).
Fields of papers citing papers by Alexander Mustea
This network shows the impact of papers produced by Alexander Mustea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander Mustea. The network helps show where Alexander Mustea may publish in the future.
Co-authors
The 25 scholars most cited alongside Alexander Mustea, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2023 | 1 | |
| 4 | 2023 | 0 | |
| 5 | 2023 | 3 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 4 | |
| 8 | 2021 | 2 | |
| 9 | 2021 | 4 | |
| 10 | 2021 | 7 | |
| 11 | 2021 | 6 | |
| 12 | 2021 | 21 | |
| 13 | 2017 | 3 | |
| 14 | 2017 | 57 | |
| 15 | 2017 | 12 | |
| 16 | Implementation of Enhanced Recovery After Surgery (ERAS) Pathways in Gynecologic Oncology. A NOGGO-AGO* survey of 144 Gynecological Departments in Germany. | 2016 | 27 |
| 17 | 2016 | 172 | |
| 18 | 2011 | 49 | |
| 19 | 2006 | 11 | |
| 20 | Hypermethylation of N33 (TUSC3) as independent molecular predictor for ovarian cancer | 2006 | 2 |
About Alexander Mustea
Alexander Mustea is a scholar working on Reproductive Medicine, Obstetrics and Gynecology, Cancer Research, Oncology and Family Practice, having authored 146 papers that have together received 3.2k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (48 papers), Endometrial and Cervical Cancer Treatments (15 papers), Uterine Myomas and Treatments (13 papers), Intraperitoneal and Appendiceal Malignancies (12 papers), MicroRNA in disease regulation (11 papers), Renal cell carcinoma treatment (10 papers), Cancer-related molecular mechanisms research (9 papers) and Endometriosis Research and Treatment (9 papers). The work is most often cited by research in Reproductive Medicine (838 citations), Obstetrics and Gynecology (440 citations), Cancer Research (837 citations), Oncology (720 citations) and Immunology (478 citations). Alexander Mustea has collaborated with scholars based in Germany, Austria and United States. Frequent co-authors include Jalid Sehouli, Dominique Koensgen, W. Lichtenegger, Dominique Könsgen, Peter Altevogt, Sascha Keller, Steffen Runz, Matthias B. Stope, Pengming Sun and Clemens Tempfer. Their work appears in journals such as Anticancer Research, Journal of Clinical Oncology, Archives of Gynecology and Obstetrics, Annals of Oncology and Gynecologic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.